Get started
Molecular Pharmacology (USA), Ltd.MM

Molecular Pharmacology (USA), Ltd.

0.000001USDD
−0.000099−99.00%
At close at Feb 13, 16:07 GMT
USD
No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

MLPH chart


Full chart

Key stats


Market capitalization
112.00 USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
0.111111
Basic EPS (TTM)
0.000900 USD
Net income (FY)
‪−8.00 K‬ USD
Revenue (FY)
0.00 USD
Shares float
‪23.55 M‬
Beta (1Y)
−86.27

About Molecular Pharmacology (USA), Ltd.


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Xin Shi
Headquarters
Stroudsburg
Founded
2002
FIGI
BBG000BVV030
Molecular Pharmacology (USA) Ltd. engages in the development of pharmaceutical products. It discovers and develops analgesic and anti-inflammatory products based on the proprietary MPL-TL compound. The MPL-TL compound is an oligopeptide which is a new key active ingredient that targets a different part of the pain and inflammation cascade than other analgesic and anti-inflammatory drugs. The company was founded on May 1, 2002 and is headquartered in Stroudsburg, PA.

Financials


Performance
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−300.00 K‬‬
‪0.00‬
‪‪300.00 K‬‬
‪‪600.00 K‬‬
‪‪900.00 K‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−5.20 K‬‬
‪‪−3.90 K‬‬
‪‪−2.60 K‬‬
‪‪−1.30 K‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−5.20 K‬‬
‪‪−3.90 K‬‬
‪‪−2.60 K‬‬
‪‪−1.30 K‬‬
‪0.00‬
Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪250.00 K‬‬
‪‪500.00 K‬‬
‪‪750.00 K‬‬
‪‪1.00 M‬‬
Debt
Free cash flow
Cash & equivalents

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MLPH is 0.000001 USD — it has decreased by −99.00% in the past 24 hours. Watch Molecular Pharmacology (USA), Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Molecular Pharmacology (USA), Ltd. stocks are traded under the ticker MLPH.
MLPH reached its all-time high on Nov 9, 2005 with the price of 2.450000 USD, and its all-time low was 0.000001 USD and was reached on Aug 17, 2021. View more price dynamics on MLPH chart.
See other stocks reaching their highest and lowest prices.
MLPH stock is ‪9.90 K‬% volatile and has beta coefficient of −72.53. Track Molecular Pharmacology (USA), Ltd. stock price on the chart and check out the list of the most volatile stocks — is Molecular Pharmacology (USA), Ltd. there?
Yes, you can track Molecular Pharmacology (USA), Ltd. financials in yearly and quarterly reports right on TradingView.
MLPH net income for the last quarter is ‪−4.92 K‬ USD, while the quarter before that showed ‪−1.08 K‬ USD of net income which accounts for −353.46% change. Track more Molecular Pharmacology (USA), Ltd. financial stats to get the full picture.
No, MLPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MLPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Molecular Pharmacology (USA), Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Molecular Pharmacology (USA), Ltd. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Molecular Pharmacology (USA), Ltd. stock shows the sell signal. See more of Molecular Pharmacology (USA), Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.